Comparison of In-vitro Activities of Linezolid and Vancomycin against Staphylococcus aureus Isolated from A Tertiary Care Hospital

Background: Methicillin resistant Staphylococcus aureus (MRSA) has emerged as one of the commonest cause of hospital acquired infections worldwide. Vancomycin is the antibiotic of choice for treatment of MRSA, but due to slow increase in vancomycin minimum inhibitory concentration (MIC) (vancomy...

Full description

Bibliographic Details
Main Authors: Sachin Kishore, Deepika Verma, ME Siddique
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2014-05-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
Online Access:https://jcdr.net/articles/PDF/4338/7751_CE(Ra)_E(C)_F(H)_PF1(AGH)_PFA(P)_PF2(PAG).pdf
_version_ 1818316953423446016
author Sachin Kishore
Deepika Verma
ME Siddique
author_facet Sachin Kishore
Deepika Verma
ME Siddique
author_sort Sachin Kishore
collection DOAJ
description Background: Methicillin resistant Staphylococcus aureus (MRSA) has emerged as one of the commonest cause of hospital acquired infections worldwide. Vancomycin is the antibiotic of choice for treatment of MRSA, but due to slow increase in vancomycin minimum inhibitory concentration (MIC) (vancomycin creep),Vancomycin has become a suboptimal therapeutic option in critically ill patients. Linezolid has emerged as an alternative drug in the treatment of such cases. Aim: To compare in vitro activities of linezolid and vancomycin against Staphylococcus aureus, in order to help in formulating a better treatment. Method: 200 strains of Staphylococcus aureus were isolated from different clinical specimens between April 2010 to March 2011. Antibiotic sensitivity testing was performed by Kirby Bauer disc diffusion method and MICs of vancomycin and linezolid were determined for all 200 strains by agar dilution method by following CLSI guidelines. Results: Among 200 strains, MIC for linezolid was 4 µg/ml for 3 strains, MIC was 2 µg/ml for 71 strains, and MIC was 1 µg/ml for 126 strains, while for the same 200 strains of Staphylococcus aureus, MIC of vancomycin was 4 µg/ml for 8 strains, it was 2 µg/ ml for 103 strains and it was 1 µg/ml for 89 strains. Conclusion: Linezolid and vancomycin had similar in-vitro efficacies for Staphylococcus aureus in disc diffusion method, but the number of strains with higher ranges of MICs of vancomycin (1-4 µg/ml) were more as compared to those which had higher ranges of MICs for linezolid. So, we suggest that linezolid can be a good alternative for the treatment of multidrug resistant Staphylococcus aureus as compared to vancomycin.
first_indexed 2024-12-13T09:29:37Z
format Article
id doaj.art-b84f61d91a4c4e94a63d0084c6d4c6f5
institution Directory Open Access Journal
issn 2249-782X
0973-709X
language English
last_indexed 2024-12-13T09:29:37Z
publishDate 2014-05-01
publisher JCDR Research and Publications Private Limited
record_format Article
series Journal of Clinical and Diagnostic Research
spelling doaj.art-b84f61d91a4c4e94a63d0084c6d4c6f52022-12-21T23:52:32ZengJCDR Research and Publications Private LimitedJournal of Clinical and Diagnostic Research2249-782X0973-709X2014-05-0185DC12DC1510.7860/JCDR/2014/7751.4338Comparison of In-vitro Activities of Linezolid and Vancomycin against Staphylococcus aureus Isolated from A Tertiary Care HospitalSachin Kishore0Deepika Verma1ME Siddique2Assistant Professor, Department of Microbiology, Rohilkhand Medical College and Hospital, Pilibhit Bypass, Bareilly-243006, UP, India.Assistant Professor, Department of Microbiology, Rohilkhand Medical College and Hospital, Pilibhit Bypass, Bareilly-243006, UP, India.Professor, Department of Microbiology, Rohilkhand Medical College and Hospital, Pilibhit Bypass, Bareilly-243006, UP, India.Background: Methicillin resistant Staphylococcus aureus (MRSA) has emerged as one of the commonest cause of hospital acquired infections worldwide. Vancomycin is the antibiotic of choice for treatment of MRSA, but due to slow increase in vancomycin minimum inhibitory concentration (MIC) (vancomycin creep),Vancomycin has become a suboptimal therapeutic option in critically ill patients. Linezolid has emerged as an alternative drug in the treatment of such cases. Aim: To compare in vitro activities of linezolid and vancomycin against Staphylococcus aureus, in order to help in formulating a better treatment. Method: 200 strains of Staphylococcus aureus were isolated from different clinical specimens between April 2010 to March 2011. Antibiotic sensitivity testing was performed by Kirby Bauer disc diffusion method and MICs of vancomycin and linezolid were determined for all 200 strains by agar dilution method by following CLSI guidelines. Results: Among 200 strains, MIC for linezolid was 4 µg/ml for 3 strains, MIC was 2 µg/ml for 71 strains, and MIC was 1 µg/ml for 126 strains, while for the same 200 strains of Staphylococcus aureus, MIC of vancomycin was 4 µg/ml for 8 strains, it was 2 µg/ ml for 103 strains and it was 1 µg/ml for 89 strains. Conclusion: Linezolid and vancomycin had similar in-vitro efficacies for Staphylococcus aureus in disc diffusion method, but the number of strains with higher ranges of MICs of vancomycin (1-4 µg/ml) were more as compared to those which had higher ranges of MICs for linezolid. So, we suggest that linezolid can be a good alternative for the treatment of multidrug resistant Staphylococcus aureus as compared to vancomycin.https://jcdr.net/articles/PDF/4338/7751_CE(Ra)_E(C)_F(H)_PF1(AGH)_PFA(P)_PF2(PAG).pdfvisamrsamic
spellingShingle Sachin Kishore
Deepika Verma
ME Siddique
Comparison of In-vitro Activities of Linezolid and Vancomycin against Staphylococcus aureus Isolated from A Tertiary Care Hospital
Journal of Clinical and Diagnostic Research
visa
mrsa
mic
title Comparison of In-vitro Activities of Linezolid and Vancomycin against Staphylococcus aureus Isolated from A Tertiary Care Hospital
title_full Comparison of In-vitro Activities of Linezolid and Vancomycin against Staphylococcus aureus Isolated from A Tertiary Care Hospital
title_fullStr Comparison of In-vitro Activities of Linezolid and Vancomycin against Staphylococcus aureus Isolated from A Tertiary Care Hospital
title_full_unstemmed Comparison of In-vitro Activities of Linezolid and Vancomycin against Staphylococcus aureus Isolated from A Tertiary Care Hospital
title_short Comparison of In-vitro Activities of Linezolid and Vancomycin against Staphylococcus aureus Isolated from A Tertiary Care Hospital
title_sort comparison of in vitro activities of linezolid and vancomycin against staphylococcus aureus isolated from a tertiary care hospital
topic visa
mrsa
mic
url https://jcdr.net/articles/PDF/4338/7751_CE(Ra)_E(C)_F(H)_PF1(AGH)_PFA(P)_PF2(PAG).pdf
work_keys_str_mv AT sachinkishore comparisonofinvitroactivitiesoflinezolidandvancomycinagainststaphylococcusaureusisolatedfromatertiarycarehospital
AT deepikaverma comparisonofinvitroactivitiesoflinezolidandvancomycinagainststaphylococcusaureusisolatedfromatertiarycarehospital
AT mesiddique comparisonofinvitroactivitiesoflinezolidandvancomycinagainststaphylococcusaureusisolatedfromatertiarycarehospital